Page last updated: 2024-10-21

homovanillic acid and Substance Withdrawal Syndrome

homovanillic acid has been researched along with Substance Withdrawal Syndrome in 65 studies

Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.

Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.

Research Excerpts

ExcerptRelevanceReference
" We measured severity of depression with Beck's Depression Inventory (BDI) and Hamilton's Depression Rating Scale (HDRS), plasma concentrations of cortisol, DHEA and DHEA-S, and CSF concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), the norepinephrine metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG) and the dopamine metabolite homovanillic acid (HVA) in 21 abstinent alcoholics after 4 weeks of abstinence and in 11 age-matched healthy control subjects."7.70Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. ( George, D; Heinz, A; Hommer, D; Linnoila, M; Weingartner, H; Wolkowitz, OM, 1999)
"Increased noradrenergic activity during chronic dopamine blockade may be an episode marker and may predict relapse within 6 weeks following haloperidol withdrawal in schizophrenia."7.69Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia. ( Agren, H; Gurklis, J; O'Connor, DT; Peters, JL; van Kammen, DP; Yao, JK, 1994)
"In the week prior to discontinuation of haloperidol treatment, global behavioral ratings and a lumbar puncture for cerebrospinal fluid monoamine metabolities were obtained in 88 patients with chronic schizophrenia."7.69Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia. ( Gilbertson, MW; Gurklis, JA; Kelley, ME; Peters, JL; van Kammen, DP; Yao, JK, 1995)
" We measured severity of depression with Beck's Depression Inventory (BDI) and Hamilton's Depression Rating Scale (HDRS), plasma concentrations of cortisol, DHEA and DHEA-S, and CSF concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), the norepinephrine metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG) and the dopamine metabolite homovanillic acid (HVA) in 21 abstinent alcoholics after 4 weeks of abstinence and in 11 age-matched healthy control subjects."3.70Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. ( George, D; Heinz, A; Hommer, D; Linnoila, M; Weingartner, H; Wolkowitz, OM, 1999)
"Increased noradrenergic activity during chronic dopamine blockade may be an episode marker and may predict relapse within 6 weeks following haloperidol withdrawal in schizophrenia."3.69Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia. ( Agren, H; Gurklis, J; O'Connor, DT; Peters, JL; van Kammen, DP; Yao, JK, 1994)
"In the week prior to discontinuation of haloperidol treatment, global behavioral ratings and a lumbar puncture for cerebrospinal fluid monoamine metabolities were obtained in 88 patients with chronic schizophrenia."3.69Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia. ( Gilbertson, MW; Gurklis, JA; Kelley, ME; Peters, JL; van Kammen, DP; Yao, JK, 1995)
" This study evaluated the safety of and pharmacologic interactions between 7 days of transdermal selegiline dosed with patches (Selegiline Transdermal System, STS) that deliver 6 mg/24 hours and 2."2.74A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion. ( Everhart, T; Harris, DS; Jacob, P; Jones, RT; Lin, E; Mendelson, JE, 2009)
"Rats treated with haloperidol also showed an increase in 5-HIAA levels, possibly due to enhanced serotonin turnover."1.27Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment. ( Barkai, AI; Kowalik, S; Reches, A, 1984)
"Clonidine's effectiveness in Tourette's syndrome may be dependent on changes in dopaminergic as well as adrenergic mechanisms."1.27Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine. Behavioral, cardiovascular, and neurochemical effects. ( Anderson, GM; Caruso, KA; Cohen, DJ; Leckman, JF; Ort, S; Riddle, MA, 1986)
"Severity of withdrawal symptoms assessed on a rating scale in 14 patients with 4 days or less of abstinence correlated marginally with HVA but not with 5-HIAA."1.26Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence. ( Banki, CM, 1981)
"Fluphenazine decanoate was administered chronically to rats on a schedule for which marked tolerance developed to acute fluphenazine effects on several parameters of dopaminergic neuronal function."1.26Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment. ( Roth, RH; Wheeler, SC, 1980)

Research

Studies (65)

TimeframeStudies, this research(%)All Research%
pre-199033 (50.77)18.7374
1990's21 (32.31)18.2507
2000's9 (13.85)29.6817
2010's2 (3.08)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirth, N1
Meinhardt, MW1
Noori, HR1
Salgado, H1
Torres-Ramirez, O1
Uhrig, S1
Broccoli, L1
Vengeliene, V1
Roßmanith, M1
Perreau-Lenz, S1
Köhr, G1
Sommer, WH1
Spanagel, R1
Hansson, AC1
Harris, DS1
Everhart, T1
Jacob, P1
Lin, E1
Mendelson, JE1
Jones, RT1
Okamoto, R1
Itoh, Y1
Murata, Y1
Kobayashi, D1
Hosoi, M1
Mine, K1
Heinz, A2
Jones, DW1
Bissette, G1
Hommer, D2
Ragan, P1
Knable, M1
Wellek, S1
Linnoila, M5
Weinberger, DR2
Roy, A2
Berman, J1
Gonzalez, B1
Roy, M1
Diaz, SL1
Kemmling, AK1
Balerio, GN1
Taylor, BK1
Basbaum, AI1
Carlson, JN1
Drew Stevens, K1
Köhnke, MD1
Lutz, U1
Kolb, W1
Maurer, S1
Wiatr, G1
Batra, A1
Barkai, AI1
Kowalik, S1
Reches, A1
Clow, A1
Theodorou, A1
Jenner, P1
Marsden, CD1
Ahluwalia, P1
Singhal, RL3
Fujimoto, A1
Banki, CM1
Petursson, H1
Bond, PA1
Smith, B1
Lader, MH1
Allikmets, LKh1
Nurk, AM1
Swann, AC1
Elsworth, JD1
Charney, DS3
Jablons, DM1
Roth, RH2
Redmond, DE1
Maas, JW1
Kuruvilla, A1
Fung, YK1
Uretsky, NJ1
Wheeler, SC1
van Kammen, DP4
Agren, H1
Yao, JK3
O'Connor, DT1
Gurklis, J1
Peters, JL2
Kelley, ME1
Gurklis, JA1
Gilbertson, MW2
Honkanen, A1
Piepponen, TP1
Ahtee, L4
Javaid, JI1
Notorangelo, MP1
Pandey, SC1
Reddy, PL1
Pandey, GN1
Davis, JM1
Paulson, PE1
Robinson, TE1
Uchimura, N1
Nakamura, J1
Hildebrand, BE3
Nomikos, GG2
Hertel, P1
Schilström, B1
Svensson, TH3
Bowers, MB2
Malison, RT1
Seibyl, JP1
Kosten, TR2
Panagis, G1
Petrakis, IL1
Trevisan, L1
D'Souza, C1
Gil, R1
Krasnicki, S1
Webb, E1
Heninger, G1
Cooney, N1
Krystal, JH2
Salminen, O1
Seppä, T1
Gäddnäs, H1
Weingartner, H1
George, D1
Wolkowitz, OM2
Ueda, M1
Hamamoto, M1
Nagayama, H1
Okubo, S1
Amemiya, S1
Katayama, Y1
Rastogi, RB2
Lapierre, YD2
Winsberg, BG1
Hurwic, MJ1
Perel, J1
Kato, N2
Takahashi, S2
Tani, N2
Iwase, N1
Odani, K1
Gramsch, C1
Bläsig, J1
Herz, A2
Siever, L1
Kraemer, H1
Sack, R1
Angwin, P1
Berger, P1
Zarcone, V2
Barchas, J1
Brodie, HK1
Sayers, AC1
Bürki, HR1
Ruch, W1
Asper, H1
Kuschinsky, K1
Svartström-Fraser, M1
McDougle, CJ2
Price, LH2
Palumbo, JM2
Heninger, GR3
Kleber, HD2
Gil, E1
Colado, I1
Lopez, F1
Fernandez-Briera, A1
Fernandez-Lopez, A1
Calvo, P1
Knoblich, G1
Curtis, D1
Faustman, WO1
Stewart, S1
Mefford, I1
King, R1
Davidson, M1
Kahn, RS1
Powchik, P1
Warne, P1
Losonczy, MF1
Kaminsky, R1
Apter, S1
Jaff, S1
Davis, KL1
Carey, RJ1
Satel, SL1
Gawin, F1
Robertson, MW1
Leslie, CA1
Bennett, JP1
Hollander, E1
Nunes, E1
DeCaria, CM1
Quitkin, FM1
Cooper, T1
Wager, S1
Klein, DF1
Modai, I1
Beigel, Y1
Cygielman, G1
Attila, P1
Lauhakangas, V1
Solkinen, A1
Sipilä, J1
Peters, J1
van Kammen, WB1
Nugent, A1
Goetz, KL1
Yao, J1
Glazer, WM1
Bagdy, G2
Perényi, A2
Frecska, E2
Révai, K2
Papp, Z1
Fekete, MI1
Arató, M1
Martin, SD1
Yeragani, VK1
Lodhi, R1
Galloway, MP1
Borg, S1
Kvande, H1
Valverius, P1
Kirch, DG1
Jaskiw, G1
Wyatt, RJ1
Leckman, JF1
Ort, S1
Caruso, KA1
Anderson, GM1
Riddle, MA1
Cohen, DJ1
Pickar, D1
Labarca, R1
Doran, AR1
Breier, A1
Paul, SM1
Papeschi, R1
Theiss, P1
Yamane, H1
Kondo, H1
Turnbull, MJ1
Ballinger, BR1

Reviews

1 review available for homovanillic acid and Substance Withdrawal Syndrome

ArticleYear
[Changes in metabolism of catecholamines and serotonin during alcohol withdrawal].
    Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55 Suppl

    Topics: Antidepressive Agents, Second-Generation; Dopamine; Ethanol; Homovanillic Acid; Humans; Hydroxyindol

1997

Trials

6 trials available for homovanillic acid and Substance Withdrawal Syndrome

ArticleYear
A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion.
    BMC clinical pharmacology, 2009, Aug-01, Volume: 9

    Topics: Administration, Cutaneous; Adult; Affect; Amphetamine; Amphetamines; Analysis of Variance; Cocaine;

2009
Memory and plasma HVA changes in schizophrenia: are they episode markers?
    Biological psychiatry, 1994, Feb-01, Volume: 35, Issue:3

    Topics: Adult; Biomarkers; Cognition Disorders; Double-Blind Method; Haloperidol; Homovanillic Acid; Humans;

1994
Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal.
    Biological psychiatry, 1998, Feb-15, Volume: 43, Issue:4

    Topics: Adult; Carrier Proteins; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Gas Chromat

1998
Clinical conditions and central dopamine metabolism in alcoholics during acute withdrawal under treatment with different pharmacological agents.
    Psychopharmacology, 1986, Volume: 88, Issue:1

    Topics: Adult; Aged; Amobarbital; Antipsychotic Agents; Butyrophenones; Double-Blind Method; Ethanol; Homova

1986
Plasma amine metabolites before and after withdrawal from neuroleptic treatment in chronic schizophrenic inpatients.
    Psychiatry research, 1988, Volume: 25, Issue:3

    Topics: Adolescent; Adult; Antipsychotic Agents; Brain; Catecholamines; Clinical Trials as Topic; Double-Bli

1988
Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment.
    Archives of general psychiatry, 1986, Volume: 43, Issue:7

    Topics: Adult; Dopamine; Female; Fluphenazine; Homovanillic Acid; Humans; Male; Middle Aged; Psychiatric Sta

1986

Other Studies

58 other studies available for homovanillic acid and Substance Withdrawal Syndrome

ArticleYear
Convergent evidence from alcohol-dependent humans and rats for a hyperdopaminergic state in protracted abstinence.
    Proceedings of the National Academy of Sciences of the United States of America, 2016, Mar-15, Volume: 113, Issue:11

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Alcohol Abstinence; Alcoholism; Animals; Benzazepines;

2016
Reduction of group II metabotropic glutamate receptors during development of benzodiazepine dependence.
    Pharmacology, 2013, Volume: 91, Issue:3-4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzodiazepines; Cerebral Cortex; Dopamine; Flumazenil; GAB

2013
Relationship between cortisol and serotonin metabolites and transporters in alcoholism [correction of alcolholism].
    Pharmacopsychiatry, 2002, Volume: 35, Issue:4

    Topics: Adult; Affect; Alcoholism; Carrier Proteins; Case-Control Studies; Corticotropin-Releasing Hormone;

2002
Cerebrospinal fluid monoamine metabolites in cocaine patients: no relationship to cue-induced craving.
    Journal of psychopharmacology (Oxford, England), 2002, Volume: 16, Issue:3

    Topics: Adult; Cocaine; Cocaine-Related Disorders; Cues; Dopamine; Female; Homovanillic Acid; Humans; Hydrox

2002
Baclofen reestablishes striatal and cortical dopamine concentrations during naloxone-precipitated withdrawal.
    Neurochemistry international, 2003, Volume: 42, Issue:4

    Topics: Animals; Baclofen; Cerebral Cortex; Chromatography, High Pressure Liquid; Dopamine; Electrochemistry

2003
Systemic morphine-induced release of serotonin in the rostroventral medulla is not mimicked by morphine microinjection into the periaqueductal gray.
    Journal of neurochemistry, 2003, Volume: 86, Issue:5

    Topics: Analgesics, Opioid; Animals; Drug Administration Routes; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Fentan

2003
Individual differences in ethanol self-administration following withdrawal are associated with asymmetric changes in dopamine and serotonin in the medial prefrontal cortex and amygdala.
    Alcoholism, clinical and experimental research, 2006, Volume: 30, Issue:10

    Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol Drinking; Amygdala; Animals; Behavior, Animal; Central Nervo

2006
Allele distribution of a monoamine oxidase A gene promoter polymorphism in German alcoholics and in subgroups with severe forms of alcohol withdrawal and its influence on plasma homovanillic acid.
    Psychiatric genetics, 2006, Volume: 16, Issue:6

    Topics: Alcoholism; Alleles; Germany; Homovanillic Acid; Humans; Monoamine Oxidase; Promoter Regions, Geneti

2006
Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment.
    Psychopharmacology, 1984, Volume: 84, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Electroshock; Haloperidol; Homovanillic Acid; Hum

1984
Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
    European journal of pharmacology, 1980, May-02, Volume: 63, Issue:2-3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Bindi

1980
Comparison of the changes in central catecholamine systems following short- and long-term lithium treatment and the consequences of lithium withdrawal.
    Neuropsychobiology, 1984, Volume: 12, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Catecholamines; Dopamine; Homovanillic Aci

1984
[Cerebrospinal fluid monamine metabolites and cyclic nucleotides during alcoholic withdrawal syndrome].
    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 1980, Volume: 82, Issue:5

    Topics: Adult; Alcoholism; Brain; Cyclic AMP; Cyclic GMP; Female; Homovanillic Acid; Humans; Hydroxyindoleac

1980
Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence.
    Journal of neural transmission, 1981, Volume: 50, Issue:2-4

    Topics: Alcoholism; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Kinetics; Phenylacetates; R

1981
Monoamine metabolism during chronic benzodiazepine treatment and withdrawal.
    Biological psychiatry, 1983, Volume: 18, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Double-Blind Method; Female; Glycols; Homovanillic Acid

1983
[Effect of chronic administration of lithium chloride on the development of dopamine receptor sensitivity during morphine withdrawal in rats].
    Biulleten' eksperimental'noi biologii i meditsiny, 1981, Volume: 92, Issue:11

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chlorides; Corpus Striatum; Dopamine; Homovanillic Acid; Hu

1981
Brain catecholamine metabolites and behavior in morphine withdrawal.
    European journal of pharmacology, 1982, Dec-24, Volume: 86, Issue:2

    Topics: Animals; Behavior, Animal; Brain Chemistry; Catecholamines; Debrisoquin; Homovanillic Acid; Humans;

1982
BehavioraL and biochemical changes caused by muscimol in mice withdrawN from haloperidol administration.
    Neuropharmacology, 1982, Volume: 21, Issue:9

    Topics: Animals; Behavior, Animal; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Humans; Male;

1982
Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment.
    Naunyn-Schmiedeberg's archives of pharmacology, 1980, Volume: 312, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain; Brain Chemistry; Cerebral Cortex; Corpu

1980
Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia.
    The American journal of psychiatry, 1994, Volume: 151, Issue:3

    Topics: Adult; Chromogranin A; Chromogranins; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Ac

1994
Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia.
    Archives of general psychiatry, 1995, Volume: 52, Issue:8

    Topics: Adult; Age of Onset; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Logistic Mode

1995
Morphine-stimulated metabolism of striatal and limbic dopamine is dissimilarly sensitized in rats upon withdrawal from chronic morphine treatment.
    Neuroscience letters, 1994, Oct-24, Volume: 180, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Limbic System

1994
Peripheral benzodiazepine receptors are decreased during cocaine withdrawal in humans.
    Biological psychiatry, 1994, Jul-01, Volume: 36, Issue:1

    Topics: Adult; Cocaine; Homovanillic Acid; Humans; Kinetics; Male; Middle Aged; Neutrophils; Radioligand Ass

1994
Regional differences in the effects of amphetamine withdrawal on dopamine dynamics in the striatum. Analysis of circadian patterns using automated on-line microdialysis.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1996, Volume: 14, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Caudate Nucleus; Circadian Rhythm; Dopamine; F

1996
Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
    Brain research, 1998, Jan-01, Volume: 779, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Dopamine; Homovanil

1998
Nicotine withdrawal in the rat: role of alpha7 nicotinic receptors in the ventral tegmental area.
    Neuroreport, 1999, Mar-17, Volume: 10, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; alpha7 Nicotinic Acetylcholine Receptor; Animals; Dopamine; Homovani

1999
CSF monoamine metabolite and beta endorphin levels in recently detoxified alcoholics and healthy controls: prediction of alcohol cue-induced craving?
    Alcoholism, clinical and experimental research, 1999, Volume: 23, Issue:8

    Topics: Adult; Alcoholism; Behavior, Addictive; Biogenic Monoamines; Biomarkers; Case-Control Studies; Ethan

1999
The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during chronic nicotine infusion and its withdrawal.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1999, Sep-15, Volume: 19, Issue:18

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Caudate Nucleus; Corpus Striatum; Cotinine; Dopam

1999
Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations.
    Psychiatry research, 1999, Dec-20, Volume: 89, Issue:2

    Topics: Adult; Case-Control Studies; Dehydroepiandrosterone; Depression; Ethanol; Female; Homovanillic Acid;

1999
Intraaccumbal mecamylamine infusion does not affect dopamine output in the nucleus accumbens of chronically nicotine-treated rats.
    Journal of neural transmission (Vienna, Austria : 1996), 2000, Volume: 107, Issue:8-9

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Chronic Disease; Dopamine; Extracellular

2000
Biochemical alterations during medication withdrawal in Parkinson's disease with and without neuroleptic malignant-like syndrome.
    Journal of neurology, neurosurgery, and psychiatry, 2001, Volume: 71, Issue:1

    Topics: Aged; Analysis of Variance; Female; Homovanillic Acid; Humans; Male; Neuroleptic Malignant Syndrome;

2001
Evidence for the role of brain norepinephrine and dopamine in "rebound" phenomenon seen during withdrawal after repeated exposure to benzodiazepines.
    Journal of psychiatric research, 1977, Volume: 13, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Body Weight; Brain; Brain Chemistry; B

1977
Neurochemistry of withdrawal emergent symptoms in children.
    Psychopharmacology bulletin, 1977, Volume: 13, Issue:3

    Topics: Antipsychotic Agents; Child; Cyclic AMP; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Hydrox

1977
Some neurochemical correlates of "rebound" phenomenon observed during withdrawal after long-term exposure to 1, 4-benzodiazepines.
    Progress in neuro-psychopharmacology, 1978, Volume: 2, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Brain; Brain Chemistry; Bromazepam; Di

1978
Changes in the metabolism of biogenic amines in alcoholism--especially regarding CSF monoamine metabolites and serum DBH activity.
    Alcoholism, clinical and experimental research, 1979, Volume: 3, Issue:1

    Topics: Adult; Aged; Alcoholism; Biogenic Amines; Dopamine beta-Hydroxylase; Female; Homovanillic Acid; Huma

1979
Changes in striatal dopamine metabolism during precipitated morphine withdrawal.
    European journal of pharmacology, 1977, Aug-01, Volume: 44, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzomorphans; Catechol O-Methyltransferase; Corpus Striatu

1977
Gradients of biogenic amine metabolites in cerebrospinal fluid.
    Diseases of the nervous system, 1975, Volume: 36, Issue:1

    Topics: Alzheimer Disease; Amphetamine; Brain Diseases; Brain Neoplasms; Depression; Homovanillic Acid; Huma

1975
Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.
    Psychopharmacologia, 1975, Volume: 41, Issue:2

    Topics: Animals; Apomorphine; Chlorpromazine; Clozapine; Corpus Striatum; Dibenzazepines; Dibenzoxazepines;

1975
Does chronic morphine treatment induce a supersensitivity of dopamine receptors in rat brain?
    Psychopharmacologia, 1975, Jun-19, Volume: 42, Issue:3

    Topics: Animals; Apomorphine; Benserazide; Brain; Corpus Striatum; Dopamine; Homovanillic Acid; Humans; Levo

1975
Effect of ethanol dependence and withdrawal on the catecholamines in rat brain and heart.
    Acta pharmacologica et toxicologica, 1975, Volume: 36, Issue:4

    Topics: Animals; Brain; Catecholamines; Depression, Chemical; Dopamine; Ethanol; Homovanillic Acid; Humans;

1975
Dopaminergic responsivity during cocaine abstinence: a pilot study.
    Psychiatry research, 1992, Volume: 43, Issue:1

    Topics: Adult; Carbidopa; Cocaine; Dopamine Agents; Drug Combinations; Growth Hormone; Homovanillic Acid; Hu

1992
Effects of chronic treatment with ethanol and withdrawal of ethanol on levels of dopamine, 3,4-dihydroxyphenylacetic acid and homovanillic acid in the striatum of the rat. Influence of benzodiazepines, barbiturate and somatostatin.
    Neuropharmacology, 1992, Volume: 31, Issue:11

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Barbiturates; Benzodiazepines; Chromatography, High Pressur

1992
Increased CSF HVA with craving in long-term abstinent cocaine abusers.
    Biological psychiatry, 1992, Jul-01, Volume: 32, Issue:1

    Topics: Adult; Arousal; Cocaine; Follow-Up Studies; Homovanillic Acid; Humans; Male; Motivation; Substance W

1992
Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
    Archives of general psychiatry, 1991, Volume: 48, Issue:1

    Topics: Adult; Antipsychotic Agents; Chronic Disease; Dopamine; Homovanillic Acid; Humans; Psychiatric Statu

1991
Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance.
    Brain research, 1991, Dec-24, Volume: 568, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Carbidopa; Corpus Striatum; Denervation; Drug

1991
Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study.
    The American journal of psychiatry, 1991, Volume: 148, Issue:12

    Topics: Adult; Cocaine; Dopamine; Female; Growth Hormone; Homovanillic Acid; Hospitalization; Humans; Male;

1991
Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment.
    Brain research, 1991, Jan-11, Volume: 538, Issue:2

    Topics: Animals; Brain Chemistry; Cocaine; Dialysis; Dopamine; Homovanillic Acid; Male; Motor Activity; Nucl

1991
Dopaminergic sensitivity and cocaine abuse: response to apomorphine.
    Psychiatry research, 1990, Volume: 33, Issue:2

    Topics: Adult; Anxiety; Apomorphine; Attention; Brain; Cocaine; Dopamine; Homovanillic Acid; Humans; Male; P

1990
Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment.
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:2

    Topics: Bipolar Disorder; Delirium; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Meta

1986
The fall of homovanillic acid and 5-hydroxyindoleacetic acid concentrations in brains of mice withdrawn from repeated morphine treatment and their restoration by acute morphine administration.
    Journal of neural transmission, 1987, Volume: 68, Issue:1-2

    Topics: Animals; Body Weight; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Morphine; M

1987
CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal.
    Biological psychiatry, 1989, Volume: 26, Issue:2

    Topics: Adult; Chromatography, High Pressure Liquid; Chronic Disease; Haloperidol; Homovanillic Acid; Humans

1989
The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia.
    Biological psychiatry, 1989, Volume: 26, Issue:3

    Topics: Antipsychotic Agents; Brain; Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; F

1989
Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment.
    Psychopharmacology, 1985, Volume: 85, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antipsychotic Agents; Chronic Disease; Dopamine; Female; Halo

1985
Clinical ratings and plasma HVA during cocaine abstinence.
    Biological psychiatry, 1989, Volume: 26, Issue:4

    Topics: Adult; Cocaine; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Substance

1989
Changes in mental condition, hyperkinesias and biochemical parameters after withdrawal of chronic neuroleptic treatment.
    Acta psychiatrica Scandinavica, 1985, Volume: 72, Issue:5

    Topics: Adult; Antipsychotic Agents; Dopamine beta-Hydroxylase; Dyskinesia, Drug-Induced; Female; Homovanill

1985
Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine. Behavioral, cardiovascular, and neurochemical effects.
    Archives of general psychiatry, 1986, Volume: 43, Issue:12

    Topics: Adolescent; Blood Pressure; Child; Clonidine; Epinephrine; Homovanillic Acid; Humans; Male; Methoxyh

1986
Serotonin and dopamine turnover after acute and chronic morphine administration.
    Arzneimittel-Forschung, 1974, Volume: 24, Issue:7

    Topics: Animals; Brain; Brain Chemistry; Dopamine; Drug Tolerance; Homovanillic Acid; Humans; Hydroxyindolea

1974
CSF monoamine metabolites in alcoholism: a comparative study with depression.
    Folia psychiatrica et neurologica japonica, 1974, Volume: 28, Issue:4

    Topics: Adult; Aged; Alcoholism; Depression; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Ma

1974
Urinary excretion of monoamines and metabolites in patients dependent on and withdrawn from barbiturates.
    Psychopharmacologia, 1973, May-21, Volume: 30, Issue:2

    Topics: Barbiturates; Catecholamines; Dopamine; Epinephrine; Female; Homovanillic Acid; Humans; Hydroxyindol

1973